Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05017311 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Study acronym: CAN-BIND-17
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 7 → 10 locations
    • Collaborators: 11 to 13
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Site contacts updated at 1 of 7 sites
    • Eligibility criteria expanded, about 3 words
    v4
  4. Lead sponsor: University Health Network, Toronto to Nova Scotia Health Authorityv3 Show 6 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Dec 31, 2023 to Dec 31, 2028
    • Start date changed from estimate of Sep 1, 2021 to Jan 20, 2023
    • Study sites: 6 to 7
    • Study completion date: Dec 31, 2023 to Apr 30, 2029
    • Collaborators: 12 to 11
  5. Eligibility criteria expanded, about 7 words
    • Study description revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study that will test a predictive biomarker algorithm based on results from a previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episode (MDE).
Trial Details
NCT Number NCT05017311
Lead Sponsor Nova Scotia Health Authority
Collaborators: Unity Health Toronto, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University, Ontario Shores Centre for Mental Health Sciences, University of Saskatchewan
Conditions
(from sponsor)		 Major Depressive Disorder
Related terms Major Depressive Disorder
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov